SCHEMBL29764346

SCHEMBL29764346

NS(=O)(=O)c1ccccc1-c1cccc2cc[nH]c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 5/20 0.47
▸ CA2 P00918 5/20 0.47
▸ CA9 Q16790 4/20 0.47
▸ NR3C1 P04150 1/20 0.46
▸ PGR P06401 1/20 0.46
▸ NR3C2 P08235 1/20 0.46
▸ AR P10275 1/20 0.46
▸ ALOX5AP P20292 2/20 0.43
▸ FEN1 P39748 2/20 0.43
▸ PDPK1 O15530 1/20 0.42
▸ AHR P35869 1/20 0.41
▸ KEAP1 Q14145 1/20 0.40
▸ ACLY P53396 1/20 0.40
▸ MAPK1 P28482 1/20 0.39
▸ CA4 P22748 2/20 0.39
▸ CA6 P23280 2/20 0.39
▸ CA12 O43570 2/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CA5A P35218 1/20 0.39
▸ CA7 P43166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30136554 0.84 AR (0.53) CA1CA2CA9NR3C1PGR
SCHEMBL1018276 0.84 AR (0.53) CA1CA2CA9NR3C1PGR
SCHEMBL29764403 0.83 ALOX5AP (0.43) CA1CA2CA9NR3C1PGR
SCHEMBL31492457 0.78 AHR (0.60) CA1CA2NR3C1PGRNR3C2
SCHEMBL29764415 0.78 NR3C1 (0.39) CA1CA2CA9NR3C1PGR
SCHEMBL29764402 0.78 CA2 (0.40) CA1CA2CA9ALOX5APFEN1
SCHEMBL29764439 0.77 CA2 (0.48) CA1CA2CA9NR3C1PGR
SCHEMBL1080972 0.76 CA2 (0.61) CA1CA2CA9ALOX5APFEN1
SCHEMBL29764456 0.76 AHR (0.44) NR3C1PGRNR3C2ARPDPK1
SCHEMBL8347239 0.74 CA2 (0.58) CA1CA2CA9ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4634155-A1 RBM39 SULFONAMIDE INHIBITORS Recursion Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
WO-2024129634-A1 RBM39 SULFONAMIDE INHIBITORS RECURSION PHARMACEUTICALS, INC. (US) 2024-06-20 — — WO disclosed
WO-2022169755-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL) BENZENESULFONAMIDES AND USES THEREOF TRIANA BIOMEDICINES, INC. (US) 2022-08-11 — — WO disclosed
Send feedback